Trial Profile
Effect of bio-absorbable everolimus-eluting stents versus permanent polymeric platinum-chromium everolimus-eluting stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Peripheral arterial occlusive disorders
- Focus Adverse reactions; Therapeutic Use
- 14 May 2015 New trial record